| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |